Menopausal status-Postmenopausal - Page 2 of 3 Posts on Medivizor
Navigation Menu

Menopausal status-Postmenopausal Posts on Medivizor

Fulvestrant: an option for estrogen-receptor positive breast cancer that has spread

Posted by on Aug 5, 2017 in Breast cancer | 0 comments

In a nutshell This study aimed to compare fulvestrant (Faslodex) to other standard endocrine agents in patients with advanced hormone sensitive breast cancer. This study concluded that fulvestrant was as effective as the available standard endocrine agents.  Some background Advanced hormone sensitive breast cancer (BC) is cancer that has...

Read More

The role of dexamethasone mouthwash in preventing everolimus-related stomatitis in women with breast cancer

Posted by on Apr 13, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated the use of dexamethasone (Ozurdex) mouthwash for preventing stomatitis in patients with breast cancer(BC).  The use of dexamethasone oral solution was found to significantly reduce the incidence and severity of stomatitis. Some background Everolimus (Afinitor) and exemestane (Aromasin) are mTOR inhibitors...

Read More

Adding bevacizumab to letrozole treatment in hormone receptor-positive metastatic breast cancer – A good idea?

Posted by on Jul 18, 2016 in Breast cancer | 0 comments

In a nutshell This study looked at the effect of adding bevacizumab (Avastin) to letrozole (Femara) treatment in patients with hormone receptor-positive (HR+) metastatic (spread to other areas) breast cancer. They found that bevacizumab treatment prolonged the amount of time before patients experienced worsening of their...

Read More

The benefits of melatonin on sleep disturbances in women with breast cancer

Posted by on Sep 15, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to determine whether or not a hormone called melatonin could positively influence the quality of life of women with breast cancer. Some background Sleep disturbance is common among women with breast cancer. Melatonin is a hormone that induces sleepiness. This hormone is naturally found in our body but may decrease...

Read More

Aromatase inhibitor treatment is associated with metabolic changes in the brain

Posted by on Dec 28, 2014 in Breast cancer | 0 comments

In a nutshell This paper studied the effect of aromatase inhibitors on cognitive function of older patients with breast cancer.  Some background Aromatase inhibitors are drugs that block the activity of estrogen receptors (proteins on cells that react to the presence of the hormone estrogen). Not only do estrogen receptors promote cell growth...

Read More

Everolimus and adverse events

Posted by on Sep 29, 2014 in Breast cancer | 0 comments

In a nutshell This paper reviewed adverse events associated with treatment of breast cancer with everolimus (Afinitus). Some background Everolimus is used in postmenopausal patients for advanced breast cancer treatments. The drug has been approved for use in patients with hormone receptor positive (the presence of the estrogen...

Read More

Anastrozole and letrozole are associated with equal rates of side effects

Posted by on Aug 3, 2013 in Breast cancer | 0 comments

In a nutshell Researchers compared therapy with anastrozole (arimidex) and letrozole (femara) to determine the effects of these drugs on the quality of life (QoL) of breast cancer patients. Some background In the case of hormone receptor positive (HR+) breast cancer, patients typically receive surgery, followed by adjuvant (additional) treatment...

Read More